大葉大學圖書館 |

登入

回首頁 到查詢結果 [ subject:"Combined Modality Therapy." ]

Pharmacology and vitreoretinal surge...

Gandorfer, Arnd.

Pharmacology and vitreoretinal surgery[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	617.7/3
書名/作者:	Pharmacology and vitreoretinal surgery/ volume editor, Arnd Gandorfer.
其他作者:	Gandorfer, Arnd.
出版者:	Basel : : S. Karger,, 2009
面頁冊數:	1 online resource : : ill. (some col.)
附註:	A change of current concepts
標題:	Retina - Surgery.
標題:	Vitreous humor.
標題:	Enzymes - Therapeutic use.
標題:	Vitreous Body - surgery.
標題:	Combined Modality Therapy.
標題:	Retina - surgery.
標題:	Retinal Diseases - surgery.
標題:	Vitrectomy - methods.
標題:	Vitreous Body - drug effects.
ISBN:	9783805590303
書目註:	Includes bibliographical references and indexes.
摘要、提要註:	Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.
電子資源:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111

Pharmacology and vitreoretinal surgery[electronic resource] /
Pharmacology and vitreoretinal surgery[electronic resource] /volume editor, Arnd Gandorfer. - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Developments in ophthalmology,v. 441662-2790 ;. - Developments in ophthalmology ;v. 43..

A change of current concepts

Includes bibliographical references and indexes.

Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.

ISBN: 9783805590303Subjects--Topical Terms:

438569
Retina
--Surgery.

LC Class. No.: RE551 / .P43 2009

Dewey Class. No.: 617.7/3

National Library of Medicine Call No.: W1 / DE998NG v.44 2009

Pharmacology and vitreoretinal surgery[electronic resource] /
LDR:02105cam a2200265 a 4500 001 350387
003 SZ-BaSKA
005 20110603112133.0
006 m d
007 cr cn|||||||||
008 111219s2009 sz ob 001 0 eng d
020 $a 9783805590303
035 $a 248111
040 $a szbaska
050 1 0 $a RE551 $b .P43 2009
060 0 0 $a W1 $b DE998NG v.44 2009
060 1 0 $a WW 250 $b P536 2009
082 0 0 $a 617.7/3 $2 22
245 0 0 $a Pharmacology and vitreoretinal surgery $h [electronic resource] / $c volume editor, Arnd Gandorfer.
260 $a Basel : $b S. Karger, $c 2009
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Developments in ophthalmology, $x 1662-2790 ; $v v. 44
500 $a A change of current concepts
504 $a Includes bibliographical references and indexes.
520 $a Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.
650 0 $a Retina $x Surgery. $3 438569
650 0 $a Vitreous humor. $3 438570
650 0 $a Enzymes $x Therapeutic use. $3 438571
650 1 2 $a Vitreous Body $x surgery. $3 438572
650 2 2 $a Combined Modality Therapy. $3 343350
650 2 2 $a Retina $x surgery. $3 438573
650 2 2 $a Retinal Diseases $x surgery. $3 438574
650 2 2 $a Vitrectomy $x methods. $3 438575
650 2 2 $a Vitreous Body $x drug effects. $3 438576
700 1 $a Gandorfer, Arnd. $3 438568
830 0 $a Developments in ophthalmology ; $v v. 43. $3 438563
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111

筆 0 讀者評論

多媒體

多媒體檔案
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111

評論

新增評論分享你的心得

Export

取書館別